HCP
ASPN icon

Hexagon Capital Partners’s Aspen Aerogels ASPN Stock Holding History

Hexagon Capital Partners’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-135
Closed -$863 – 205
2025
Q1 		$863 Buy
+135
New +$1.3K ﹤0.01% 1575

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Hexagon Capital Partners's ASPN Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 135 shares — an estimated $863 sold.

Hexagon Capital Partners first reported a position in ASPN in Q1 2025 and held it in 1 quarter. The position peaked at $863 in Q1 2025. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 135 Aspen Aerogels shares in Q2 2025, an estimated $863.
  • Hexagon Capital Partners first reported a position in Aspen Aerogels in Q1 2025 and held it in 1 quarter.
  • Hexagon Capital Partners's Aspen Aerogels position peaked at $863 in Q1 2025.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.